There is no benefit in the use of postnatal intravenous immunoglobulin for the prevention of relapses of multiple sclerosis: findings from a systematic review and meta-analysis by Gleysson Rodrigues Rosa, Anthony Terrence O’Brien, Eduardo de Almeida Guimarães Nogueira, Vitor Martinez de Carvalho, Sonia Castedo Paz, Yara Dadalti Fragoso

Get full text